Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

About The Journal Open Access

Journal of Cancer Clinical Research

Journal of Cancer Clinical Research is a peer reviewed, open access periodical dedicated to publish the clinical advancements in the cancer research and therapy providing end-to-end solutions, from diagnosis thorough various stages of cancer therapy, pharmaceutical advancements, drug delivery, clinical trials, rehabilitation and care. Journal of Cancer Clinical Research provides a forum for the exchange of information on all aspects related to cancer diagnosis and therapy by including expert’s opinions as editorials.

You may submit manuscripts online at https://www.scholarscentral.org/submissions/cancer-clinical-research.html or you may send the article as an email attachment to the following mail-id: ccr@alliedacademiesscholars.com.

Individuals interested in becoming members of the Editorial/Review Board should contact by email.

Fast Editorial Execution and Review Process (FEE-Review Process):

Journal of cancer clinical research is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

Please submit your manuscript to
editorialservice@alliedacademies.org

Just Published Articles View More

Rapid Communication August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Fibrosis-Related Biomarkers in Cardiovascular Medicine: Pathophysiological and Prognostic Significance of Galectin-3 and ST2

Ajay Kirtane

DOI:

Rapid Communication August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Key Functions of the Angiotensin II Pathway in Cardiovascular Regulation and Disorders

Roxana Mehran

DOI:

Short Communication August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Exploring the Mechanisms and Clinical Significance of Myocardial Stiffness in Cardiovascular Health

Thomas Lüscher

DOI:

Short Communication August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Late Gadolinium Enhancement in Cardiac MRI: Diagnostic and Prognostic Implications

Samin Sharma

DOI:

Perspective August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Interstitial Fibrosis in Cardiac Pathophysiology: The Silent Architect of Myocardial Remodeling

Kim Eagle

DOI:

Perspective August 19, 2025

P.1-2

J Cancer Clin Res: 8(1): 1-2

Transforming Growth Factor-�² (TGF-�²) as a Central Regulator in Physiological and Pathological Processes

Jagat Narul

DOI:

Relevant Topics

Get the App